Hinrich P Hansen Selected Research

BB 3644

9/2004	Metalloproteinase inhibition augments antitumor efficacy of the anti-CD30 immunotoxin Ki-3(scFv)-ETA' against human lymphomas in vivo.
3/2002	Inhibition of metalloproteinases enhances the internalization of anti-CD30 antibody Ki-3 and the cytotoxic activity of Ki-3 immunotoxin.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Hinrich P Hansen Research Topics

Disease

17	Neoplasms (Cancer) 01/2020 - 03/2002
8	Hodgkin Disease (Hodgkin's Disease) 01/2021 - 04/2004
4	Lymphoma (Lymphomas) 01/2021 - 05/2004
2	Hematologic Neoplasms (Hematological Malignancy) 01/2021 - 08/2010
2	Melanoma (Melanoma, Malignant) 01/2019 - 01/2016
2	B-Cell Chronic Lymphocytic Leukemia (Chronic Lymphocytic Leukemia) 01/2017 - 05/2013
2	Carcinoma (Carcinomatosis) 06/2014 - 06/2011
2	Granulomatosis with Polyangiitis (Wegener's Granulomatosis) 06/2004 - 05/2002
2	Autoimmune Diseases (Autoimmune Disease) 06/2004 - 04/2004
1	Fibrosis (Cirrhosis) 01/2022
1	Leukemia 01/2016
1	Breast Neoplasms (Breast Cancer) 03/2013
1	Prostatic Neoplasms (Prostate Cancer) 06/2011
1	Hypercholesterolemia 05/2007
1	Multiple Myeloma 03/2006
1	Severe Combined Immunodeficiency (Bare Lymphocyte Syndrome) 09/2004
1	Vasculitis (Vasculitides) 06/2004
1	Rare Diseases (Rare Disease) 06/2004
1	Immune System Diseases (Immune Disorders) 04/2004
1	Non-Hodgkin Lymphoma (Lymphosarcoma) 04/2004
1	Churg-Strauss Syndrome (Allergic Angiitis) 05/2002
1	Systemic Vasculitis 05/2002
1	Atopic Dermatitis (Atopic Eczema) 01/2002

Drug/Important Bio-Agent (IBA)

8	LigandsIBA 01/2016 - 03/2006
4	Natural Killer Cell ReceptorsIBA 01/2016 - 08/2009
4	Proteins (Proteins, Gene)FDA Link 06/2014 - 03/2006
3	AntigensIBA 01/2016 - 06/2004
3	Metalloproteases (Metalloproteinases)IBA 03/2013 - 03/2002
3	AntibodiesIBA 06/2004 - 05/2002
2	NK Cell Lectin-Like Receptor Subfamily KIBA 01/2016 - 03/2006
2	Immunotoxins (Immunotoxin)IBA 03/2013 - 09/2004
2	BB 3644IBA 09/2004 - 03/2002
1	MicroRNAs (MicroRNA)IBA 01/2022
1	CollagenIBA 01/2022
1	Brentuximab VedotinIBA 01/2021
1	Tumor Necrosis Factor Receptors (Tumor Necrosis Factor Receptor)IBA 01/2021
1	Immunoconjugates (Immunoconjugate)IBA 01/2021
1	AcetylesteraseIBA 01/2019
1	Endosomal Sorting Complexes Required for TransportIBA 01/2019
1	Messenger RNA (mRNA)IBA 01/2017
1	CD30 LigandIBA 05/2016
1	Retinoic Acid Receptors (Retinoic Acid Receptor)IBA 01/2016
1	Carcinoembryonic AntigenIBA 06/2014
1	Recombinant Fusion ProteinsIBA 06/2014
1	Inhibitor of Apoptosis ProteinsIBA 10/2013
1	Bispecific AntibodiesIBA 04/2013
1	Pharmaceutical PreparationsIBA 03/2013
1	DisintegrinsIBA 03/2013
1	Monoclonal AntibodiesIBA 03/2013
1	PanobinostatIBA 01/2013
1	Histone Deacetylase InhibitorsIBA 01/2013
1	Membrane Proteins (Integral Membrane Proteins)IBA 06/2011
1	Heat-Shock Proteins (Heat-Shock Protein)IBA 08/2009
1	6- chloro- 9- (4- methoxy- 3,5- dimethylpyridin- 2- ylmethyl)- 9H- purin- 2- ylamineIBA 08/2009
1	Gemcitabine FDA Link 08/2009
1	Doxorubicin (Adriamycin)FDA LinkGeneric 08/2009
1	NF-kappa B (NF-kB)IBA 08/2009
1	Annexin A5IBA 08/2009
1	Molecular Chaperones (Chaperone, Molecular)IBA 08/2009
1	Natural Cytotoxicity Triggering Receptor 3IBA 12/2007
1	HLA-B Antigens (HLA-B)IBA 12/2007
1	HLA Antigens (Human Leukocyte Antigens)IBA 12/2007
1	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 05/2007
1	Simvastatin (Zocor)FDA LinkGeneric 05/2007
1	3- (formylhydroxyamino)- 2- (3- phenyl- 1- propyl)butanoic acid (2,2- dimethyl- 1- methylcarbamoyl- 1- propyl)amideIBA 01/2007
1	Interferon-gamma (Interferon, gamma)IBA 03/2006
1	Neoplasm Antigens (Tumor Antigens)IBA 03/2006
1	Ki-3(scFv)-ETA'IBA 09/2004
1	Adrenal Cortex Hormones (Corticosteroids)IBA 06/2004
1	AutoantigensIBA 06/2004
1	Antineutrophil Cytoplasmic Antibodies (ANCA)IBA 06/2004
1	Cyclophosphamide (Cytoxan)FDA LinkGeneric 06/2004
1	CholesterolIBA 04/2004
1	methyl-beta-cyclodextrinIBA 04/2004
1	anti-endothelial cell antibodyIBA 05/2002
1	Fibronectins (Fibronectin)IBA 05/2002
1	VitronectinIBA 05/2002
1	AutoantibodiesIBA 05/2002
1	Antigen-Antibody Complex (Immune Complex)IBA 05/2002
1	GlucocorticoidsIBA 01/2002

Therapy/Procedure

4	Immunotherapy 05/2016 - 03/2002
2	Therapeutics 01/2020 - 01/2002
1	Transplantation 01/2019
1	Hematopoietic Stem Cell Transplantation 08/2010